Skip to main content

Table 4 Treatment-related adverse events occurring in all subjects

From: Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study

Adverse event Period 1 (n = 12) Period 2 (n = 12)
Patients with ≥1 treatment-related adverse event, n (%) 12 (100) 12 (100)
Blood and lymphatic system disorders   
Lymphadenopathy 6 (50) 7 (58.3)
General disorders and administration site conditions   
Injection site discomfort 0 (0.0) 1 (8.3)
Injection site pain 3 (25.0) 5 (41.7)
Edema peripheral 12 (100) 12 (100)
Injury, poisoning and procedural complications   
Contusion 12 (100) 12 (100)
Skin laceration 2 (16.7) 2 (16.7)
Musculoskeletal and connective tissue disorders   
Pain in extremity 11 (91.7) 11 (91.7)
Nervous system disorders   
Paresthesia 1 (8.3) 0 (0.0)
Skin and subcutaneous tissue disorders   
Blood blister 0 (0.0) 2 (16.7)
Pruritus 5 (41.7) 10 (83.3)
Skin discoloration 0 (0.0) 1 (8.3)